Global Next Generation Dna Sequencing Ngs Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 9.40 Billion |
 Market Size (Forecast Year) |
USD 40.42 Billion |
 CAGR |
% |
| Major Markets Players |
|
全球下一代DNA测序 (NGS) 市场，按产品（仪器、消耗品、服务）、应用（诊断、生物标志物发现、精准医疗、药物发现、农业和动物研究等）、最终用户（制药和生物技术公司、研究中心和学术和政府研究所、医院和诊所）– 行业趋势和预测到 2029 年。
全球下一代 DNA 测序 (NGS) 市场分析和规模
近年来，由于癌症的高发病率，预计下一代 DNA 测序 (NGS) 市场将在预测期内快速增长。下一代测序是一种 DNA 测序方法，可确定 DNA 分子内核苷酸的精确排列。下一代测序仪每秒生成一百万个 DNA 分子和 RNA 序列，从而实现快速测序。下一代测序是指高通量测序 (NSG)。
- Data Bridge Market Research 分析称，2021 年下一代 DNA 测序 (NGS) 市场价值为 94 亿美元，预计到 2029 年将达到 404.2 亿美元，在 2022 年至 2029 年的预测期内复合年增长率为 20%。Data Bridge Market Research 团队策划的市场报告包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
全球下一代 DNA 测序 (NGS) 市场定义
确定 DNA 片段中核苷酸序列的方法称为下一代测序或高通量测序。合成测序 (SBS)、离子半导体测序、纳米孔测序和单分子实时 (SMRT) 测序是所使用的一些技术。这是一种经济高效的解决方案，可提供精确、高精度和快速的结果。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制至 2019 - 2014） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
产品（仪器、消耗品、服务）、应用（诊断、生物标志物发现、精准医疗、药物发现、农业和动物研究等）、最终用户（制药和生物技术公司、研究中心和学术及政府机构、医院和诊所） |
|
覆盖国家 |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
|
Market Players Covered |
Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), PerkinElmer, Inc. (US), BGI Group (China), Agilent Technologies, Inc. (US), Eurofins Scientific (Luxembourg), PacBio (US), Oxford Nanopore Technologies plc (UK), QIAGEN (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), GENEWIZ Inc. (US), Psomagen (South Korea), 10x Genomics (US), Takara Bio Inc (Japan), Bio-Rad Laboratories, Inc. (US), Zymo Research Corporation (US), Tecan Trading AG (Switzerland), Hamilton Company (US), Beckman Coulter, Inc. (US), BD (US), Lucigen Corporation (US), and Novogene Co., Ltd. (China) |
|
Market Opportunities |
|
Next Generation DNA Sequencing (NGS) Market Dynamics
Drivers
-
Increasing Prevalence of Chronic Diseases
The rising prevalence of chronic diseases such as cancer will propel the market’s growth rate during the forecast period of 2022-2029. There has been a tremendous growth in the use of NGS technology as a result of the widespread acceptance of liquid biopsies in cancer diagnoses. Cell-free circulating tumor DNA (ctDNA) is used as a non-invasive cancer biomarker for real-time cancer monitoring and detection in these technologies.
-
Rise in the Adoption of Genome Mapping Programs
The market is also benefiting from the growing use of genomic mapping programmes to anticipate the development of various diseases. Scientists utilize genetic maps to help them figure out which genes are linked to rising rates of diabetes, heart disease, asthma, cancer, and psychiatric disorders.
Furthermore, the growing geriatric population will act as major factor influencing the growth of next generation DNA sequencing (NGS) market. Along with this, increasing urbanization and rising level of disposable income are the driving factors accelerating the growth of the next generation DNA sequencing (NGS) market. Also, increasing expenditure on healthcare infrastructure and rising use of NGS technology by pharmaceutical and biopharmaceutical companies are the major market drivers that will further escalate the growth of next generation DNA sequencing (NGS) market.
Opportunities
-
Increase in the Number of Research and Development Activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities in the field of molecular biology, sequencing chemistry and technical engineering. This will provide beneficial opportunities for the next generation DNA sequencing (NGS) market growth.
Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the next generation DNA sequencing (NGS) market growth during the forecast period.
Restraints/Challenges Global Next Generation DNA Sequencing (NGS) Market
On the other hand, the high cost associated with next generation DNA sequencing (NGS) will obstruct the growth rate of market. The dearth of skilled professionals and rising risk of infection will challenge the next generation DNA sequencing (NGS) market. Additionally, impact of COVID-19 on supply chain and introduction of alternative technology will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.
This next generation DNA sequencing (NGS) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the next generation DNA sequencing (NGS) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Next Generation DNA Sequencing (NGS) Market
The dissemination use COVID-19 had a huge impact on numerous sectors around the world; the primary goal was to alleviate the global crisis. Pharmaceutical and biopharmaceutical industries, on the other hand, have grown tremendously as a result of pandemics. During the outbreak, developing self-test kits, therapies, and vaccinations were considered critical operations. As a result, various startups and established market players have raised their investments to support the process, assisting the next generation sequencing industry's overall growth. As a result, governmental entities have increased their research and development efforts in the next generation sequencing sector. The need of continuous supply and research was recognized by market participants, who boosted their investments in the industry as a result of the pandemic, resulting in higher Next Generation Sequencing market growth.
Recent Development
- 2021年1月，华大基因集团地中海贫血基因检测试剂盒（组合探针锚合成测序法）获得CE标志批准，可用于á、â地中海贫血和其他血红蛋白病的基因诊断以及一般人群携带者筛查。
全球下一代 DNA 测序 (NGS) 市场范围
下一代 DNA 测序 (NGS) 市场根据产品、应用和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
产品
- 仪器
- 耗材
- 服务
根据产品，下一代 DNA 测序 (NGS) 市场分为仪器、消耗品和服务。
应用
- 诊断
- 生物标志物发现
- 精准医疗
- 药物研发
- 农业和动物研究
- 其他的
根据应用，下一代 DNA 测序 (NGS) 市场细分为诊断、生物标志物发现、精准医疗、药物发现、农业和动物研究等。
最终用户
- 制药和生物技术公司
- 研究中心和学术
- 政府机构
- 医院和诊所
下一代 DNA 测序 (NGS) 市场也根据最终用户细分为制药和生物技术公司、研究中心和学术和政府机构、医院和诊所。
下一代 DNA 测序 (NGS) 市场区域分析/见解
对下一代 DNA 测序 (NGS) 市场进行了分析，并按国家、产品、应用和最终用户提供了市场规模洞察和趋势，如上所述。
下一代 DNA 测序 (NGS) 市场报告涵盖的国家包括北美的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
北美在下一代 DNA 测序 (NGS) 市场中占据主导地位，因为该地区拥有完善的医疗基础设施，并且人们对先进治疗方法的认识不断提高。此外，主要关键参与者的存在将促进该地区市场的增长率。
由于亚太地区遗传病患病率上升和生殖健康意识增强，预计预测期内亚太地区将出现增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
下一代 DNA 测序 (NGS) 市场还为您提供每个国家/地区资本设备医疗保健支出增长、下一代 DNA 测序 (NGS) 市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对下一代 DNA 测序 (NGS) 市场的影响的详细市场分析。数据适用于 2010-2020 年的历史时期。
竞争格局和下一代 DNA 测序 (NGS) 市场份额分析
下一代 DNA 测序 (NGS) 市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对下一代 DNA 测序 (NGS) 市场的关注有关。
下一代 DNA 测序 (NGS) 市场的一些主要参与者包括：
- Illumina 公司（美国）
- 赛默飞世尔科技公司（美国）
- PerkinElmer, Inc.（美国）
- 华大基因集团（中国）
- 安捷伦科技公司（美国）
- Eurofins Scientific（卢森堡）
- PacBio (美国)
- 牛津纳米孔技术有限公司（英国）
- QIAGEN（荷兰）
- F. Hoffmann-La Roche Ltd.（瑞士）
- GENEWIZ Inc.（美国）
- Psomagen（韩国）
- 10x Genomics（美国）
- Takara Bio Inc（日本）
- Bio-Rad Laboratories, Inc.（美国）
- Zymo 研究公司 (美国)
- Tecan Trading AG（瑞士）
- 汉密尔顿公司（美国）
- 贝克曼库尔特公司（美国）
- BD（美国）
- Lucigen Corporation（美国）
- 诺禾致源股份有限公司 (中国)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
